Propanc Biopharma, Inc. Common Stock share price logo

Propanc Biopharma, Inc. Common Stock Share Price

NASDAQ: PPCB

Small Cap

$0.11

(+3.20%)

as on

Propanc Biopharma, Inc. Common Stock Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    $0.10
    $0.11
    downward going graph

    9.09%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.10
    $10.81
    downward going graph

    13.64%

    Downside

    9727.27%

    Upside

    downward going graph

Propanc Biopharma, Inc. Common Stock share price movements today

Previous Close
$0.11
Open
$0.10
Volume
5.3M
Day's Low - High
$0.10 - $0.11
52 Week Low - High
$0.10 - $10.81

Propanc Biopharma, Inc. Common Stock Historical Returns

1 Month Return
-11.05 %
3 Month Return
-66.09 %
1 Year Return
-98.67 %
3 Year Return
-100 %
5 Year Return
0 %

Propanc Biopharma, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Propanc Biopharma, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-3.3222247191011234

PEG Ratio

0

Return On Equity TTM

-1811.69%

Propanc Biopharma, Inc. Common Stock Stock Valuation

Track how Propanc Biopharma, Inc. Common Stock P/E has moved over time to understand its valuation trends.

Propanc Biopharma, Inc. Common Stock in the last 5 years

  • Overview

  • Trends

Lowest (-1.78x)

June 30, 2024

Industry (-3.32x)

April 17, 2026

Today (0.00x)

April 17, 2026

Highest (-0.04x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Propanc Biopharma, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Propanc Biopharma, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Propanc Biopharma, Inc. Common Stock image
Propanc Biopharma, Inc. Common Stock
NA$2.4MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Stock Returns calculator for Propanc Biopharma, Inc. Common Stock Stock including INR - Dollar returns

The Propanc Biopharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Propanc Biopharma, Inc. Common Stock investment value today

Current value as on today

₹1,494

Returns

-₹98,506

(-98.51%)

Returns from Propanc Biopharma, Inc. Common Stock Stock

-₹98,625 (-98.63%)

Dollar Impact

₹119 (+0.12%)

Propanc Biopharma, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Propanc Biopharma, Inc. Common Stock Stock has increased by 182% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:182% versus previous 30 day period

Propanc Biopharma, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
0
0
0
0
0
-53
-3
-4
-3
EBITDA
0
0
0
0
0
0
-53
-3
-1
-3
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
0
0
0
-54
-4
-4
-3
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
0
0
0
0
0
0
-54
-4
-4
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-13615.11%
0.00%
0.00%

Propanc Biopharma, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-6
-5
-3
-2
-3
-1
-1
-1
-1
-57
EBITDA
-4
-4
-4
-4
-3
-1
-2
-2
-1
-58
Interest Expense
4
3
2
1
1
0
0
0
0
0
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-8
-7
-5
-4
-2
-2
-2
-1
-58
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-9
-7
-7
-5
-4
-2
-2
-2
-1
-58
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Propanc Biopharma, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
0
0
0
0
-54
-4
-4
-3
Operating Cash Flow
0
0
0
0
0
0
0
-1
0
Investing Cash Flow
-
-
-
-
-
-
-
0
0
Financing Cash Flow
0
0
0
0
0
0
0
2
0
Change in Cash
0
0
0
0
0
0
0
0
0

Propanc Biopharma, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-7
-7
-5
-4
-2
-2
-2
-1
-58
Operating Cash Flow
-2
-2
-2
-1
-1
-1
-1
0
0
Investing Cash Flow
0
0
0
-
-
-
-
-
-
Financing Cash Flow
2
2
2
1
1
1
1
0
0
Change in Cash
0
0
0
0
0
0
0
0
0

Insights on Propanc Biopharma, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 121.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 137.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PPCB stock has moved down by -66.1%

About Propanc Biopharma, Inc. Common Stock

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.
OrganisationPropanc Biopharma, Inc. Common Stock
Headquarters302, 6 Butler Street, Camberwell, VIC, Australia, 3124
IndustryBiotechnology
CEOMr. James Nathanielsz
E-voting on sharesClick here to vote

Key Management of Propanc Biopharma, Inc. Common Stock

Name

Title

Mr. James Nathanielsz

CEO & Executive Chairman

Ms. Jeannine Zimmerman

Chief Financial Officer

Prof. Klaus Kutz M.D.

Chief Medical Officer & Member of Scientific Advisory Board

FAQs

What is Propanc Biopharma, Inc. Common Stock share price today?

Propanc Biopharma, Inc. Common Stock share price today is $0.11 as on at the close of the market. Propanc Biopharma, Inc. Common Stock share today touched a day high of $0.11 and a low of $0.1.

What is the 52 week high and 52 week low for Propanc Biopharma, Inc. Common Stock share?

Propanc Biopharma, Inc. Common Stock share touched a 52 week high of $10.81 on and a 52 week low of $0.1 on . Propanc Biopharma, Inc. Common Stock stock price today i.e. is closed at $0.11,which is 98.98% down from its 52 week high and 15.79% up from its 52 week low.

What is Propanc Biopharma, Inc. Common Stock's market capitalisation today?

Propanc Biopharma, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in Propanc Biopharma, Inc. Common Stock Stock (PPCB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Propanc Biopharma, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Propanc Biopharma, Inc. Common Stock Shares that will get you 13.6364 shares as per Propanc Biopharma, Inc. Common Stock share price of $0.11 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Propanc Biopharma, Inc. Common Stock Stock (PPCB) from India?

Indian investors can start investing in Propanc Biopharma, Inc. Common Stock (PPCB) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Propanc Biopharma, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Propanc Biopharma, Inc. Common Stock share’s latest price of $0.11 as on April 18, 2026 at 1:29 am IST, you will get 90.9091 shares of Propanc Biopharma, Inc. Common Stock. Learn more about fractional shares .